Skip to content

Clinical trials

Completed Phase 3 Hypersensitivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 3 Status: Completed Clear all

79 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20043
20053
20066
200710
20086
20092
20104
20113
20121
20136
20142
20153
20161
20175
20186
20202
20214
20222
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed79

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ALK-Abelló A/S12
Allergopharma GmbH & Co. KG6
Aimmune Therapeutics, Inc.5
Stallergenes Greer5
AstraZeneca4
Colgate Palmolive4
Alcon Research3
Ellodi Pharmaceuticals, LP3
Allergy Therapeutics2
Bayer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity79
Hypersensitivity, Immediate11
Rhinitis, Allergic11
Immune System Diseases10
Rhinitis, Allergic, Seasonal9
Rhinitis7
Asthma6
Gastroenteritis6
Eczema5
Eosinophilia5

Trials

Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.